Literature DB >> 17588331

Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain.

Jing-jing Duan1, Ji-hua Ma, Pei-hua Zhang, Xian-pei Wang, An-rou Zou, Dan-na Tu.   

Abstract

AIM: The objectives of this study were to investigate the inhibitory action of verapamil on wild-type(WT) and mutation HERG K+ channel current (I(HERG)), and to determine whether mutations in the S6 region are important for the inhibition of I(HERG) by verapamil.
METHODS: HERG channels (WT, Y652A, and F656A) were expressed in oocytes of Xenopus laevis and studied using the 2-electrode voltage- clamp technique.
RESULTS: WT HERG is blocked in a concentration-dependent manner by verapamil (half-maximal inhibition concentration [IC(50)]=5.1 micromol/L), and the steady state activation and inactivation parameters are shifted to more negative values. However, mutation to Ala of Y652 and F656 located on the S6 domain produced 16-fold and 20-fold increases in IC(50) for IHERG blockade, respectively. Simultaneously, the steady state activation and inactivation parameters for Y652A are also shifted to more negative values in the presence of the blockers.
CONCLUSION: Verapamil preferentially binds to and blocks open HERG channels. Tyr-652 and Phe-656, 2 aromatic amino-acid residues in the inner (S6) helix, are critical in the verapamil-binding site.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588331     DOI: 10.1111/j.1745-7254.2007.00562.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  16 in total

1.  Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels.

Authors:  Menghang Xia; Sampada A Shahane; Ruili Huang; Steven A Titus; Enoch Shum; Yong Zhao; Noel Southall; Wei Zheng; Kristine L Witt; Raymond R Tice; Christopher P Austin
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-26       Impact factor: 4.219

2.  hERG ion channel pharmacology: cell membrane liposomes in porous-supported lipid bilayers compared with whole-cell patch-clamping.

Authors:  Yanli Zhang; Thai Phung; James Dunlop; Julie Dalziel
Journal:  Eur Biophys J       Date:  2012-08-31       Impact factor: 1.733

3.  Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin.

Authors:  Daniel Scherer; Katharina von Löwenstern; Edgar Zitron; Eberhard P Scholz; Ramona Bloehs; Sven Kathöfer; Dierk Thomas; Alexander Bauer; Hugo A Katus; Christoph A Karle; Claudia Kiesecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

4.  Mechanism of HERG potassium channel inhibition by tetra-n-octylammonium bromide and benzethonium chloride.

Authors:  Yan Long; Zuoxian Lin; Menghang Xia; Wei Zheng; Zhiyuan Li
Journal:  Toxicol Appl Pharmacol       Date:  2013-01-08       Impact factor: 4.219

5.  Current use of domperidone and co-prescribing of medications that increase its arrhythmogenic potential among older adults: a population-based cohort study in Ontario, Canada.

Authors:  Carlos Rojas-Fernandez; Anne L Stephenson; Hadas D Fischer; Xuesong Wang; Tiago Mestre; Janine R Hutson; Margarita Pondal; Douglas S Lee; Paula A Rochon; Connie Marras
Journal:  Drugs Aging       Date:  2014-11       Impact factor: 3.923

Review 6.  Arrhythmic risk biomarkers for the assessment of drug cardiotoxicity: from experiments to computer simulations.

Authors:  A Corrias; X Jie; L Romero; M J Bishop; M Bernabeu; E Pueyo; B Rodriguez
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2010-06-28       Impact factor: 4.226

7.  A case for pharmacogenomics in management of cardiac arrhythmias.

Authors:  Gaurav Kandoi; Anjali Nanda; Vinod Scaria; Sridhar Sivasubbu
Journal:  Indian Pacing Electrophysiol J       Date:  2012-04-30

8.  Development and validation of an automated high-throughput system for zebrafish in vivo screenings.

Authors:  Ainhoa Letamendia; Celia Quevedo; Izaskun Ibarbia; Juan M Virto; Olaia Holgado; Maria Diez; Juan Carlos Izpisua Belmonte; Carles Callol-Massot
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

9.  Optimisation of embryonic and larval ECG measurement in zebrafish for quantifying the effect of QT prolonging drugs.

Authors:  Sundeep Singh Dhillon; Eva Dóró; István Magyary; Stuart Egginton; Attila Sík; Ferenc Müller
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

10.  Structural basis of ion permeation gating in Slo2.1 K+ channels.

Authors:  Priyanka Garg; Alison Gardner; Vivek Garg; Michael C Sanguinetti
Journal:  J Gen Physiol       Date:  2013-11       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.